Back to SLNCF
GOLDMAN SACHS GROUP INC → SLNCF
GOLDMAN SACHS GROUP INC SLNCF Position History
Silence Therapeutics plc • Healthcare
Quarters held
7
Latest value
$5.1M
Q3 2026
Peak value
$5.1M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $69K |
| Q3 2025 | $118K |
| Q4 2025 | $110K |
| Q4 2025 | $110K |
| Q1 2026 | $277K |
| Q2 2026 | $1.7M |
| Q3 2026 | $5.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.1M | 462.8K | — | — |
| Q2 2026 | $1.7M | 155.9K | — | — |
| Q1 2026 | $277K | 52.5K | — | — |
| Q4 2025 | $110K | 18.1K | — | — |
| Q4 2025 | $110K | 18.1K | — | — |
| Q3 2025 | $118K | 22.6K | — | — |
| Q1 2025 | $69K | 24.4K | — | — |
Other funds holding SLNCF
$44.5M
$36.4M
$31.6M
$29.4M
$26.9M
$26.6M